Recombinant Pneococcal Protein Vaccine

· CanSino Biologics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant Pneococcal Protein Vaccine, covering 2024-12-04 to 2024-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Recombinant Pneumococcal Protein Vaccine [Phase 1]